Drug Trial Radar · NCT07393334
Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive
Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Dec 2, 2025
Primary completion
Mar 2026
Study completion May 2026
Sponsor
- Lead sponsor
- Next Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
NLS-133-CLIN001 is a Phase 2a study designed to assess the safety, tolerability, and effects of NLS-133 (combination of two FDA-approved agents) compared to an active control (FDA-approved pharmacologic agent) or placebo on semen volume and sperm count in 10 in healthy men. Participants will be randomized in a crossover design to receive a single dose of NLS-133, an active control or placebo either 90 or 180 minutes prior to collection of semen. Sperm parameters measured will be count, motility and morphology. A brief questionnaire will be completed by each subject during each treatment cycle that addresses orgasm and ejaculation quality. Safety monitoring will include adverse event reporting, laboratory assessments, and vital signs.
Conditions
- Male Contraception
- Semen Volume
- Sperm Motility
Interventions
NLS-133Drug
NLS-133 is the primary experimental arm of the study
PlaceboDrug
Double placebo arm of the study
Active Comparator #1Drug
Active control arm of study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Semen volume (mL)Time frame: 90 and 180 minutes for each treatment cycle
- Sperm count (millions/mL)Time frame: 90 and 180 minutes for each treatment cycle
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Population Center for Research in Human Reproduction and Departments of Medicine, University of Washington
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.